• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO (US) 2.5/26; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO (US) 2.5/26; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 401760
Device Problem Use of Device Problem (1670)
Patient Problem Vascular Dissection (3160)
Event Date 06/01/2020
Event Type  Injury  
Event Description
An orsiro drug-eluting stent system was selected for treatment.Osiro stent placed to om1, culprit lesion.Small dissection noted after.Another osiro stent placed to dissected area distal to initial stent, however overlapping.Patient is stable.
 
Manufacturer Narrative
Combination product: yes.Neither the complaint instrument nor the angiographic material was provided for analysis.Therefore, no technical investigation on the subject could be performed.The production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for the reported event.Review of the production documentation for the product detailed above verified that the instrument was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.Based on the conducted investigations no manufacturing related root cause could be identified.It should be noted that, according to the physician, the orsiro us was properly deployed and the perforation was successfully sealed with the second orsiro.The stent information worksheet clearly states that there was no malfunction with the complaint device.It further should be noted that the ifu clearly states that pre-dilatation is mandatory.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO (US) 2.5/26
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key10368325
MDR Text Key201717845
Report Number1028232-2020-03248
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier07640130439153
UDI-Public07640130439153
Combination Product (y/n)N
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,study
Type of Report Initial,Followup
Report Date 06/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/13/2021
Device Model Number401760
Device Catalogue NumberSEE MODEL NO.
Device Lot Number05193862
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/08/2020
Initial Date FDA Received08/05/2020
Supplement Dates Manufacturer Received10/06/2020
Supplement Dates FDA Received10/07/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-